Tolterodine and Clarithromycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tolterodine (tolterodine tartrate) and Clarithromycin (clarithromycin). Common drug interactions include local swelling among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Tolterodine and Clarithromycin. It is created by eHealthMe based on reports of 74 people who take the same drugs from the FDA, and is updated regularly.

What is Tolterodine?

Tolterodine has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 8,156 Tolterodine users. Check the latest studies of Tolterodine.

What is Clarithromycin?

Clarithromycin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 45,044 Clarithromycin users. Check the latest studies of Clarithromycin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 21, 2026

74 people who take Tolterodine and Clarithromycin together, and have interactions are studied.

Tolterodine and Clarithromycin drug interactions.

What are the common drug interactions of Tolterodine and Clarithromycin, by gender? *:

female:

  1. Local swelling (swelling at the site of some application of substance or injury)
  2. Lower respiratory tract infection
  3. Mobility decreased (ability to move is reduced)
  4. Mood altered (changes in mood)
  5. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Pain in extremity
  8. Psychological trauma
  9. Rash
  10. Renal failure (kidney dysfunction)

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Lung infection
  3. Blood phosphorus increased
  4. Blood pressure fluctuation
  5. Blood pressure increased
  6. Cardiac failure
  7. Decreased appetite
  8. Dehydration (dryness resulting from the removal of water)
  9. Diarrhoea
  10. Discomfort

What are the common drug interactions of Tolterodine and Clarithromycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood pressure fluctuation
  2. Blood urea increased
  3. Blood uric acid increased
  4. Depression
  5. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  6. Hypotension (abnormally low blood pressure)
  7. Hypovolaemia (a decreased volume of circulating blood in the body)
  8. Sluggishness (lacking alertness)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Weight increased

50-59:

  1. Death
  2. Drug hypersensitivity
  3. Chronic kidney disease
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal failure (kidney dysfunction)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Haematemesis (vomiting of blood)
  3. Vomiting
  4. Hypersomnia (excessive daytime sleepiness (eds))
  5. Mania (a state of abnormally elevated or irritable mood)
  6. Pain
  7. Psychotic disorder
  8. Vision blurred
  9. Weight decreased
  10. Diplopia (double vision)

What are the existing conditions these people have? *

  1. Lower Respiratory Tract Infection: 26 people, 35.14%
  2. Stress And Anxiety: 24 people, 32.43%
  3. Bladder Irritation: 23 people, 31.08%
  4. Depression: 20 people, 27.03%
  5. Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 15 people, 20.27%
  6. Cardiac Failure: 11 people, 14.86%
  7. High Blood Pressure: 9 people, 12.16%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 9.46%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 8.11%
  10. Pain: 6 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Tolterodine and Clarithromycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tolterodine and Clarithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tolterodine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Clarithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tolterodine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clarithromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tolterodine tartrate and clarithromycin (the active ingredients of Tolterodine and Clarithromycin, respectively), and Tolterodine and Clarithromycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: